PCA
IBB icon

Providence Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Providence Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.8K Hold
135
– – ﹤0.01% 160
2025
Q4 		$22.8K Hold
135
– – ﹤0.01% 176
2025
Q3 		$19.5K Hold
135
– – ﹤0.01% 178
2025
Q2 		$17.1K Buy
+135
New +$16.6K ﹤0.01% 184
2024
Q4 		– Sell
-135
Closed -$19.7K – 210
2024
Q3 		$19.7K Hold
135
– – ﹤0.01% 218
2024
Q2 		$18.5K Hold
135
– – ﹤0.01% 209
2024
Q1 		$18.5K Hold
135
– – ﹤0.01% 207
2023
Q4 		$18.3K Sell
135
-50
-27% -$6.1K ﹤0.01% 217
2023
Q3 		$22.6K Hold
185
– – 0.01% 200
2023
Q2 		$23.5K Hold
185
– – 0.01% 184
2023
Q1 		$23.9K Hold
185
– – 0.01% 180
2022
Q4 		$24.3K Hold
185
– – 0.01% 173
2022
Q3 		$22K Hold
185
– – 0.01% 175
2022
Q2 		$22K Hold
185
– – 0.01% 180
2022
Q1 		$24K Hold
185
– – 0.01% 205
2021
Q4 		$28K Hold
185
– – 0.01% 181
2021
Q3 		$30K Hold
185
– – 0.01% 175
2021
Q2 		$30K Hold
185
– – 0.01% 166
2021
Q1 		$28K Hold
185
– – 0.01% 165
2020
Q4 		$28K Buy
+185
New +$26.4K 0.01% 170
2020
Q1 		– Sell
-15
Closed -$2K – 270
2019
Q4 		$2K Buy
+15
New +$1.67K ﹤0.01% 238
2018
Q4 		– Sell
-175
Closed -$21K – 262
2018
Q3 		$21K Buy
+175
New +$20.6K 0.01% 167
2018
Q1 		– Sell
-33
Closed -$4K – 277
2017
Q4 		$4K Buy
+33
New +$3.53K ﹤0.01% 275

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Providence Capital Advisors's IBB Position: Q1 2026 in Review

Providence Capital Advisors held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 135 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #160.

Providence Capital Advisors first reported a position in IBB in Q4 2017 and has held it in 23 quarters since. The position peaked at $30K in Q3 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Providence Capital Advisors held 135 shares of iShares Biotechnology ETF worth $22.8K as of Q1 2026.
  • Providence Capital Advisors left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Providence Capital Advisors's portfolio in Q1 2026, its #160 holding.
  • Providence Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 23 quarters since.
  • Providence Capital Advisors's iShares Biotechnology ETF position peaked at $30K in Q3 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Providence Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.